Anti-diabetic effects of ethanol extract of bryonia laciniosa seeds and its saponins rich fraction in neonatally streptozotocin-induced diabetic rats

Pharmacognosy Research

Volumn 7, Issue 1, 2015, Pages 92-99

  Patel, Sandip ^a   Santani, Devdas ^b   Patel, Veena ^c   Shah, Mamta ^d  

^a Indukaka Ipcowala College of Pharmacy   (India)

^b Rofel Shri GM Bilakhia College of Pharmacy   (India)

^c Anand College of Pharmacy   (India)

^d L M COLLEGE OF PHARMACY   (India)

Author keywords

Diabetes mellitus; dyslipidemia; hyperglycemia; oxidative stress

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL; ANTIDIABETIC AGENT; ASPARTATE AMINOTRANSFERASE; BRYONIA LACINIOSA EXTRACT; CATALASE; CHOLESTEROL; CREATININE; GLIBENCLAMIDE; GLUCOSE; GLUTATHIONE; HIGH DENSITY LIPOPROTEIN; INSULIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; PLANT EXTRACT; SAPONIN DERIVATIVE; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; UREA; VERY LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ARTICLE; BRYONIA; BRYONIA LACINIOSA; CLINICAL EVALUATION; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFICACY; DRUG MECHANISM; DYSLIPIDEMIA; ENZYME ACTIVITY; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; LIVER FUNCTION TEST; NEWBORN; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; OXIDATIVE STRESS; PLANT SEED; RAT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; UREA BLOOD LEVEL;

EID: 84919982257     PISSN: None     EISSN: 09748490     Source Type: Journal    
DOI: 10.4103/0974-8490.147217     Document Type: Article

References (42)

1. Wang Y, Xin X, Jin Z, Hu Y, Li X, Wu J, et al. Anti-diabetic effects of pentamethylquercetin in neonatally streptozotocin-induced diabetic rats. Eur J Pharmacol 2011;668:347-53.
2. Andrade-Cetto A, Revilla-Monsalve C, Wiedenfeld H. Hypoglycemic effect of Tournefortia hirsutissima L. on n-streptozotocin diabetic rats. J Ethnopharmacol 2007;112:96-100.
3. Li L, Yi Z, Seno M, Kojima I. Activin A and betacellulin: Effect on regeneration of pancreatic beta-cells in neonatal streptozotocin-treated rats. Diabetes 2004;53:608-15.
4. Thyssen S, Arany E, Hill DJ. Ontogeny of regeneration of beta-cells in the neonatal rat after treatment with streptozotocin. Endocrinology 2006;147:2346-56.
5. Tiwari AK, Rao JM. Diabetic mellitus and multiple therapeutic approaches of phytochemicals: Present status and future prospects. Curr Sci 2002;83:30-7.
6. Zhang LH, Xiao PG. Recent advances in studies of antihyperlipaemic and antihyperglycaemic compounds from Chinese traditional and herbal medicines. Phytother Res 1993;7:217-26.
7. Xu R, Zhao W, Xu J, Shao B, Qin G. Studies on bioactive saponins from Chinese medicinal plants. Adv Exp Med Biol 1996;404:371-82.
8. Xi M, Hai C, Tang H, Chen M, Fang K, Liang X. Antioxidant and antiglycation properties of total saponins extracted from traditional Chinese medicine used to treat diabetes mellitus. Phytother Res 2008;22:228-37.
9. Kirtikar K, Basu B. Indian Medicinal Plants. 2 nd ed. Allahabad: The Indian Press; 1987.
10. Nadkarni K. Indian Materia Medica. Bombay, India: Popular Book Depot; 1927.
11. Gabrielian SE, Gevorgovich A. Bryonia, as novel plant adoptogen, for prevention and treatment of stress induced disorders. Promising Res Abstr PRA 1997;(5003):1-8.
12. Acharya D. Shivlingi: A common but important twine in Patalkot. Am Chron 2007.
13. Saxena N, Balyari N, Srivastva A. Pharmacological studies of novel pharmaceutical saponin molecules of seeds of Bryonia laciniosa. New Delhi, India: IUPAC. Internationational Conference on Biodiversity, Natural Product Chemistry and Medicinal Applications; 2004. p. 368.
14. Gowrikumar G, Mani VV, Chandrasekhararao T, Kaimal TN, Lakshminarayana G. Diplocyclos palmatus L: A new seed source of punicic acid. Lipids 1981;116:558-9.
15. Mosaddik MA, Ekramul Haque M, Abdur Rashid M. Goniothalamin from Bryonopsis laciniosa Linn (Cucurbiataceae). Biochem Syst Ecol 2000;28:1039-040.
16. Singh V, Malviya T, Tripathi DN, Naraian U. An escherichia coli antimicrobial effect of arabinoglucomannan from fruit of Bryonia lacinosa. Carbohydr Polym 2009;75:534-37.
17. Mosaddik MA, Haque ME. Cytotoxicity and antimicrobial activity of goniothalamin isolated from Bryonopsis laciniosa. Phytother Res 2003;17:1155-7.
18. Gupta M, Mazumdar UK, Sivakumar T, Vamsi ML, Karki SS, Sambathkumar R, et al. Evaluation of anti-inflammatory activity of chloroform extract of Bryonia laciniosa in experimental animal models. Biol Pharm Bull 2003;26:1342-4.
19. Karageuzyan K, Vartanyan G, Agadjanov M. Restoration of disordered glucose-fatty acid cycle in alloxan-diabetic rats by trihydrixyoctadecdienoic acids from Bryonia alba-A native americal plant. Planta Med 1998;64:417-22.
20. Patel S, Santani D, Shah M, Patel V. Anti-hyperglycemic and Anti-hyperlipidemic Effects of Bryonia Laciniosa Seed Extract and its saponin fraction in streptozotocin-induced Diabetes in Rats. J Young Pharm 2012;4:171-6.
21. Hiai S, Oura H, Nakajima T. Color reaction of some sapogenins and saponins with vanillin and sulfuric acid. Planta Med 1976;29:116-22.
22. Mihara M, Uchiyama M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 1978;86:271-8.
23. Sedlak J, Lindsay RH. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman′s reagent. Anal Biochem 1968;25:192-205.
24. Misra HP, Fridovich I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 1972;247:3170-5.
25. Takahara S, Hamilton HB, Neel JV, Kobara TY, Ogura Y, Nishimura ET. Hypocatalasemia: A new genetic carrier state. J Clin Invest 1960;39:610-9.
26. Weyer C, Bogardus C, Mott DM, Pratley RE. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 1999;104:787-94.
27. Portha B, Picon L, Rosselin G. Chemical diabetes in the adult rat as the spontaneous evolution of neonatal diabetes. Diabetologia 1979;17:371-7.
28. Bonora E, Zavaroni I, Coscelli C, Butturini U. Decreased hepatic insulin extraction in subjects with mild glucose intolerance. Metabolism 1983;32:438-46.
29. Carnevale Schianca GP, Rossi A, Sainaghi PP, Maduli E, Bartoli E. The significance of impaired fasting glucose versus impaired glucose tolerance: Importance of insulin secretion and resistance. Diabetes Care 2003;26:1333-7.
30. Hannan JM, Rokeya B, Faruque O, Nahar N, Mosihuzzaman M, Azad Khan AK, et al. Effect of soluble dietary fibre fraction of Trigonella foenum graecum on glycemic, insulinemic, lipidemic and platelet aggregation status of type 2 diabetic model rats. J Ethnopharmacol 2003;88:73-7.
31. Maghrani M, Lemhadri A, Jouad H, Michel JB, Eddouks M. Effect of the desert plant Retama raetam on glycaemia in normal and streptozotocin-induced diabetic rats. J Ethnopharmacol 2003;87:21-5.
32. Sachdewa A, Khemani LD. Effect of Hibiscus rosa sinensis Linn. ethanol flower extract on blood glucose and lipid profile in streptozotocin induced diabetes in rats. J Ethnopharmacol 2003;89:61-6.
33. Yin J, Hu R, Chen M, Tang J, Li F, Yang Y, et al. Effects of berberine on glucose metabolism in vitro. Metabolism 2002;51:1439-43.
34. Fujimoto WY. The importance of insulin resistance in the pathogenesis of type 2 diabetes mellitus. Am J Med 2000;108 Suppl 6a: 9S-14S.
35. Inoguchi T, Li P, Umeda F, Yu HY, Kakimoto M, Imamura M, et al. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 2000;49:1939-45.
36. Celik S, Erdogan S, Tuzcu M. Caffeic acid phenethyl ester (CAPE) exhibits significant potential as an antidiabetic and liver-protective agent in streptozotocin-induced diabetic rats. Pharmacol Res 2009;60:270-6.
37. Nosadini R, Tonolo G. Relationship between blood glucose control, pathogenesis and progression of diabetic nephropathy. J Am Soc Nephrol 2004;15 Suppl 1:S1-5.
38. Shinde UA, Goyal RK. Effect of chromium picolinate on histopathological alterations in STZ and neonatal STZ diabetic rats. J Cell Mol Med 2003;7:322-9.
39. Thrailkill KM, Clay Bunn R, Fowlkes JL. Matrix metalloproteinases: Their potential role in the pathogenesis of diabetic nephropathy. Endocrine 2009;35:1-10.
40. Stehouwer CD, Schaper NC. The pathogenesis of vascular complications of diabetes mellitus: One voice or many? Eur J Clin Invest 1996;26:535-43.
41. Rahimi R, Nikfar S, Larijani B, Abdollahi M. A review on the role of antioxidants in the management of diabetes and its complications. Biomed Pharmacother 2005;59:365-73.
42. Evans JL, Maddux BA, Goldfine ID. The molecular basis for oxidative stress-induced insulin resistance. Antioxid Redox Signal 2005;7:1040-52.